Publication | Closed Access

Rationale, design, and baseline characteristics of 2 large, simple, randomized trials evaluating telmisartan, ramipril, and their combination in high-risk patients: the Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial/Telmisartan Randomized Assessment Study in ACE Intolerant Subjects with Cardiovascular Disease (ONTARGET/TRANSCEND) trials

ThrombosisHypertensionOngoing Telmisartan AloneNon-pharmacological InterventionHealth PolicyCardiovascular DiseaseAntihypertensive TherapyClinical TrialsCardiovascular PharmacologyPharmacotherapyBaseline CharacteristicsPublic HealthMedicineAtherosclerosis